Stock Price Quote

LINCOLN PHARMACEUTICALS LTD.

NSE : LINCOLNBSE : 531633ISIN CODE : INE405C01035Industry : Pharmaceuticals & DrugsHouse : Private
BSE311.70-3.9 (-1.24 %)
PREV CLOSE ( ) 315.60
OPEN PRICE ( ) 316.30
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3276
TODAY'S LOW / HIGH ( )302.85 326.55
52 WK LOW / HIGH ( )255 379.9
NSE312.10-3.8 (-1.2 %)
PREV CLOSE( ) 315.90
OPEN PRICE ( ) 311.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 312.10 (330)
VOLUME 50888
TODAY'S LOW / HIGH( ) 301.30 327.00
52 WK LOW / HIGH ( )255 379.05
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 20-01 1995
Management Info
Kishor M Shah - Chairman Mahendra G Patel - Managing Director
Registered Office

Address Lincoln House", Behind Satyam Complex,Science City Road,Sola,
Ahmedabad,
Gujarat-380060

Phone 079-41078000

Email investor@lincolnpharma.com

Website www.lincolnpharma.com

Registrars Details
Link Intime India Pvt Ltd.
506-508, 5th Floor, Amaranth Business Complex - I (ABC - I),Beside Gala Business Center, St. Xaviers Corner, Off C.G. Road,Navrangpura,Ahmedabad
Listing : BSE, NSE, Ahmedabad

NEWS

16Dec Lincoln Pharmaceuticals informs about
Lincoln Pharmaceuticals has informed that the exchange has received the..
07Dec Lincoln Pharmaceuticals informs about
Lincoln Pharmaceuticals has informed that the exchange has received the..
03Dec Lincoln Pharmaceuticals informs about
The Exchange has received the disclosure under Regulation 29(2) of SEBI..
30Nov Lincoln Pharmaceuticals informs about
Lincoln Pharmaceuticals has informed that the exchange has received the..
24Nov Lincoln Pharmaceuticals informs about
In compliance with Regulation 23(9) of the SEBI (Listing Obligations and..

Financials

in Millions
QTR Sep 22 ANNUAL 22
Net Profit237.12693.55
Gross Profit 320.32 959.29
Operating Profit 345.931054.68
Net Sales 1406.124720.79

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  20867.55 (1.87%)
M.Cap ( in Cr)44342.09
Themis Medicare (BSE)
peergroup  1273.80 (4.48%)
M.Cap ( in Cr)1172.25
Piramal Enterprises (BSE)
peergroup  876.55 (3.42%)
M.Cap ( in Cr)20920.07
Neuland Laboratories (BSE)
peergroup  1424.60 (1.70%)
M.Cap ( in Cr)1827.75
Hester Biosciences (BSE)
peergroup  1818.35 (1.30%)
M.Cap ( in Cr)1546.85

Shareholding Pattern

NON-INSTITUTION 52.22%
PROMOTERS 46.34%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
Motilal Oswal S&P B...0.06

About Lincoln Pharmaceuticals Ltd.

Lincoln Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 311.7. Its current market capitalisation stands at Rs 624.33 Cr. In the latest quarter, company has reported Gross Sales of Rs. 4965.31 Cr and Total Income of Rs.4820.77 Cr. The company's management includes Trusha Shah, Saurin J Parikh, Meha Patel, Pirabhai Suthar, Anand A Patel, Rajnikant G Patel, Munjal M Patel, H I Patel, Ashish Patel, Mahendra G Patel, Kishor M Shah.

It is listed on the BSE with a BSE Code of 531633 , NSE with an NSE Symbol of LINCOLN and ISIN of INE405C01035. It's Registered office is at Lincoln House", Behind Satyam Complex,Science City Road,SolaAhmedabad-380060, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Chandulal M Shah & Co, DK Chhajer & Co, JT Shah & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)